programmed cell death protein 1 inhibitor
Showing 1 - 3 of 3
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Plaque, Atherosclerotic, Immune Checkpoint Inhibitors, Programmed Cell Death Protein 1 Inhibitor Trial in Hangzhou (PD-1 immune
Recruiting
- Plaque, Atherosclerotic
- +4 more
- PD-1 immune checkpoint blockades
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University, School of
Nov 16, 2021
Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Artery
Recruiting
- Plaque, Atherosclerotic
- Programmed Cell Death Protein 1 Inhibitor
- PD-1 inhibitor
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Jun 5, 2021